Quantitative proteomics in lung cancer
Quantitative proteomics in lung cancer
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Lung cancer is the most common cause of cancer-related death worldwide, less than 7% of patients survive 10 years following diagnosis across all stages of lung cancer. Late stage of diagnosis and lack of effective and personalized medicine reflect the need for a better understanding of the mechanisms that underlie lung cancer progression. Quantitat...
Alternative Titles
Full title
Quantitative proteomics in lung cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_e7c9a8e8db2c4424a7f6dfef13d567dd
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e7c9a8e8db2c4424a7f6dfef13d567dd
Other Identifiers
ISSN
1423-0127,1021-7770
E-ISSN
1423-0127
DOI
10.1186/s12929-017-0343-y
